| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | - | - | - |
| Operating Income | ¥-2.9B | ¥-3.1B | +7.1% |
| Ordinary Income | ¥-2.8B | ¥-3.1B | +8.4% |
| Net Income | ¥-2.7B | ¥-3.1B | +13.1% |
| ROE | -6.5% | -7.2% | - |
FY2026 Q2 results show persistent operating losses with modest sequential improvement: Operating loss of 2.9B yen (prior period loss 3.1B, YoY improvement +7.1%), Ordinary loss of 2.8B yen (prior 3.1B, +8.4% improvement), and Net loss of 2.7B yen (prior 3.1B, +13.1% improvement). Despite continued negative profitability, loss amounts decreased across all major income metrics. The company maintains a robust cash position of 40.1B yen against minimal debt of 1.2B yen, providing a strong financial buffer. Total assets decreased to 42.7B yen from 45.0B yen, while equity declined to 41.5B yen from 43.7B yen, reflecting accumulated losses. Basic EPS improved to negative 16.20 yen from negative 18.67 yen, representing 13.2% improvement in per-share loss reduction. Operating cash flow was negative 2.7B yen with minimal change YoY (+0.3%), while free cash flow remained deeply negative at 3.9B yen, indicating ongoing cash consumption from both operations and investments.
Revenue data was not disclosed in the XBRL filings for this interim period, limiting top-line growth analysis. However, loss reduction across operating, ordinary, and net income levels indicates improved cost management or non-recurring benefits. SG&A expenses totaled 2.6B yen while R&D expenses accounted for 1.1B yen, representing substantial ongoing investment in product development. Operating loss narrowed by 0.2B yen YoY, driven primarily by controlled administrative costs despite continued R&D investment. The gap between operating loss of 2.9B yen and ordinary loss of 2.8B yen was minimal at 0.1B yen, indicating limited non-operating activity impact. Non-operating income and expenses were each recorded at 0.0B yen (negligible amounts), suggesting core operations drove the P&L outcome. Extraordinary income of 0.1B yen was recorded with minimal extraordinary losses, though impairment loss of 2.9M yen was noted for corporate assets not allocated to segments. The minimal gap between ordinary loss of 2.8B yen and net loss of 2.7B yen (difference of 0.1B) reflects the small extraordinary income benefit and negligible tax expense (0.0B yen), consistent with loss-making status. This represents a revenue-undisclosed/loss-reduced pattern, where profitability metrics improved despite lack of top-line visibility.
The company operates two reportable segments: DTxProduct and DTxPlatform. DTxProduct segment recorded operating loss of 1.0B yen with no revenue disclosed, indicating this remains a development-stage business consuming resources. DTxPlatform segment generated revenue of 0.9B yen with operating income of 0.5B yen, achieving a strong operating margin of 58.2%. DTxPlatform represents the core revenue-generating business with positive profitability, while DTxProduct remains in investment phase. Segment profit/loss adjustments represent unallocated corporate expenses primarily consisting of general administrative costs not attributable to specific segments. The aggregated segment losses reconcile to the consolidated operating loss of 2.9B yen. The substantial margin differential between segments (DTxPlatform at 58.2% positive versus DTxProduct deeply negative) highlights the bifurcated nature of the business model, with one platform-based segment achieving strong unit economics while the product segment requires continued development investment.
[Profitability] ROE of negative 6.5% reflects ongoing net losses against a substantial equity base of 41.5B yen, though loss reduction improved this metric from prior levels. Operating margin and net margin cannot be calculated due to undisclosed revenue, but the operating loss to total assets ratio of 6.8% indicates material loss generation relative to asset base. [Cash Quality] Cash and deposits of 40.1B yen provide coverage of 33.4x against current liabilities of 1.2B yen, indicating exceptional short-term liquidity. The current ratio of approximately 3497% and quick ratio at similar levels demonstrate no near-term solvency concerns. [Investment Efficiency] Asset turnover cannot be calculated without revenue disclosure. Return on invested capital was deeply negative at negative 198.4% per quality alerts, reflecting substantial capital consumption without positive returns. Intangible assets increased to 0.6B yen from 0.2B yen YoY (+292.9%), indicating continued capitalization of development costs. [Financial Health] Equity ratio of 97.2% demonstrates minimal financial leverage, with total liabilities of only 1.2B yen against total assets of 42.7B yen. Debt-to-equity ratio of 0.03x confirms virtually no debt financing. However, retained earnings remained deeply negative at negative 14.9B yen, representing accumulated losses that have eroded 35.9% of total equity. Financial leverage stood at 1.03x, indicating conservative capital structure.
Operating cash flow of negative 2.7B yen represents 1.01x coverage of net loss of 2.7B yen, confirming that reported losses are cash-backed with minimal accrual distortion. Operating cash flow before working capital changes was negative 2.7B yen, matching the total operating CF and indicating negligible working capital impact. Contract liabilities decreased by 0.1B yen, suggesting limited deferred revenue accumulation. Investing cash flow of negative 1.2B yen was primarily driven by intangible asset acquisitions of 0.4B yen rather than tangible CapEx (minimal at 0.0B yen), reflecting the digital/intellectual property nature of the business model. Financing cash flow was effectively neutral at 0.0B yen with minimal share repurchases of 0.0B yen, indicating no significant capital raising or return activities. Free cash flow of negative 3.9B yen (operating CF plus investing CF) indicates continued cash consumption exceeding 9.2% of total assets, though the substantial cash balance of 40.1B yen provides multi-year runway at current burn rates. The company's cash position decreased by 2.6B yen YoY from 42.7B yen, reflecting the cumulative negative FCF impact.
Ordinary loss of 2.8B yen versus operating loss of 2.9B yen shows net non-operating contribution of approximately 0.1B yen, representing minimal impact from financial activities. Non-operating income and expenses were each recorded at negligible levels (0.0B yen), indicating operations drove nearly all P&L activity. The small extraordinary income of 0.1B yen represented 0.2% of total assets and stemmed from non-recurring items, with offsetting impairment loss of 2.9M yen on corporate assets due to negative operating cash flows and impaired recoverability. Operating cash flow matched net loss almost exactly at 1.01x coverage, indicating high earnings quality in that reported losses are cash-realized rather than accrual-driven. The minimal gap between operating, ordinary, and net losses suggests transparent earnings with limited distortion from one-time items, financial engineering, or tax effects. The company's loss-making position with near-zero tax expense (0.0B yen) and minimal non-operating activity produces straightforward earnings quality assessment: reported losses accurately reflect economic reality and cash consumption.
No formal earnings guidance or forecast data was disclosed in the XBRL filings for this interim period, limiting progress rate analysis. The forecast notes indicate that forward-looking statements are based on currently available information and reasonable assumptions, with actual results potentially differing materially due to various factors. Without disclosed full-year guidance, interim progress cannot be quantified against annual targets. Order backlog or contract liability data shows contract liabilities of 0.3B yen, representing limited forward revenue visibility equivalent to approximately 0.3x quarterly DTxPlatform revenue run rate. This suggests modest near-term revenue backlog relative to quarterly consumption rates.
The company maintains a zero dividend policy with no dividends paid during the interim period and forecasted annual dividend of 0.00 yen. This is consistent with the loss-making status and strategic prioritization of cash preservation for R&D and business development. With net losses of 2.7B yen, dividend payout ratio is not applicable. No share buyback activity was reported, with treasury shares remaining minimal at 6K shares against total outstanding of 16,868K shares. Total shareholder return ratio is effectively zero, reflecting the company's stage of development where cash is directed entirely toward business investment rather than capital returns. The retained deficit of 14.9B yen and ongoing operating losses support the continuation of zero dividend policy until profitability is achieved.
Commercialization execution risk: R&D expenses of 1.1B yen and intangible asset investments of 0.4B yen represent substantial ongoing development investment, yet revenue generation remains limited (DTxProduct segment shows no revenue), creating risk that product pipeline fails to achieve commercial viability or market acceptance before cash reserves are depleted.
Asset impairment risk: Intangible assets increased 292.9% YoY to 0.6B yen while operating losses persist, and the company recorded 2.9M yen impairment on corporate assets due to negative operating cash flows. If recoverability assessments worsen, material impairments could further erode equity and signal failed investments.
Cash consumption sustainability: Free cash flow of negative 3.9B yen represents 9.7% of cash reserves consumed in a six-month period. At current burn rate, the 40.1B yen cash balance provides approximately 5 years of runway, but acceleration of losses or investment needs could compress this timeline and necessitate dilutive financing.
[Industry Position] (Reference - Proprietary Analysis)
SusMed's financial profile diverges materially from IT/Telecom industry medians, reflecting its pre-revenue development stage versus established peers.
Profitability: ROE of negative 6.5% substantially underperforms industry median of 5.6% (2025-Q2, n=7), with the company loss-making versus peers generating positive returns. Operating margin is not calculable due to undisclosed revenue, though DTxPlatform segment's 58.2% margin exceeds industry median of 14.0%, while consolidated operations remain loss-making versus industry median profitability.
Financial Health: Equity ratio of 97.2% significantly exceeds industry median of 60.2% (IQR: 50.8-88.4%), indicating ultra-conservative capital structure. Current ratio materially exceeds industry median of 7.74x (IQR: 3.16-8.09x), reflecting exceptional liquidity positioning. Financial leverage of 1.03x is well below industry median of 1.55x (IQR: 1.13-1.76x), consistent with minimal debt utilization.
Efficiency: Return on invested capital of negative 198.4% substantially trails industry median of 11.0% (IQR: 2.0-29.0%), reflecting capital consumption without returns. Cash conversion ratio of approximately 1.01x aligns reasonably with industry median of 1.22x (IQR: 0.86-1.75x), indicating losses are cash-realized. Asset turnover is not calculable without revenue disclosure.
Growth: EPS improved 13.2% YoY (loss reduction) versus industry median EPS growth of 35.0% (IQR: 12.0-47.0%), though comparison is distorted by the company's negative earnings base. FCF yield is deeply negative versus industry median of 3.0% (IQR: 1.0-8.0%), consistent with development-stage cash consumption.
The company's financial profile reflects a development-stage business model incompatible with operating peer benchmarks, exhibiting fortress balance sheet positioning offset by persistent unprofitability and capital inefficiency.
(Industry: IT/Telecom, Comparison: FY2025-Q2 industry data where available, Source: Proprietary analysis)
Strong liquidity buffer supports extended development runway: Cash position of 40.1B yen against minimal liabilities (equity ratio 97.2%) and current quarterly cash burn of approximately 2B yen provides multi-year financial flexibility to execute R&D strategy without near-term financing pressure, distinguishing the company from capital-constrained peers in development stage.
Bifurcated business model with one profitable platform: DTxPlatform segment demonstrates viable unit economics with 58.2% operating margin and 0.9B yen revenue, while DTxProduct segment remains in pure investment phase with no revenue and 1.0B yen operating loss, indicating potential for margin expansion if product pipeline commercializes successfully but with binary outcome risk.
Sequential loss reduction trend warrants monitoring for inflection: Operating loss improved 7.1% YoY, ordinary loss improved 8.4%, and net loss improved 13.1%, representing modest but consistent narrowing of losses across all income levels, though absolute loss levels remain material at 2.7-2.9B yen and path to profitability remains unclear without disclosed revenue growth trajectory or commercialization milestones.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.